aTYR PHARMA INC (ATYR) › Shareholders' EquityaTYR PHARMA INC (ATYR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$64.55M2013: -$66.08M2014: -$91.01M2015: $115.05M2016: $62.80M2017: $64.25M2018: $33.65M2019: $21.19M2020: $31.65M2021: $109.30M2022: $71.46M2023: $90.66M2024: $70.02M2025: $67.48M$67.48M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$67.48M-3.6%2024$70.02M-22.8%2023$90.66M+26.9%2022$71.46M-34.6%2021$109.30M+245.3%2020$31.65M+49.4%2019$21.19M-37.0%2018$33.65M-47.6%2017$64.25M+2.3%2016$62.80M-45.4%2015$115.05M+226.4%2014-$91.01M-37.7%2013-$66.08M-2.4%2012-$64.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share